Veritas Asset Management Llp Trimmed Thermo Fisher Scientific (TMO) Position By $48.62 Million; Amica Pension Fund Board Of Trustees Trimmed By $538,160 Its Leggett & Platt (LEG) Holding

Leggett & Platt, Incorporated (NYSE:LEG) Logo

Amica Pension Fund Board Of Trustees decreased Leggett & Platt Inc (LEG) stake by 80.46% reported in 2018Q4 SEC filing. Amica Pension Fund Board Of Trustees sold 15,376 shares as Leggett & Platt Inc (LEG)’s stock rose 17.60%. The Amica Pension Fund Board Of Trustees holds 3,734 shares with $134,000 value, down from 19,110 last quarter. Leggett & Platt Inc now has $5.65B valuation. The stock increased 0.16% or $0.07 during the last trading session, reaching $43.13. About 556,126 shares traded. Leggett & Platt, Incorporated (NYSE:LEG) has risen 8.65% since March 15, 2018 and is uptrending. It has outperformed by 4.28% the S&P500. Some Historical LEG News: 26/04/2018 – LEGGETT & PLATT INC LEG.N FY2018 SHR VIEW $2.75 — THOMSON REUTERS l/B/E/S; 26/04/2018 – Leggett & Platt Had Seen 2018 Sales $4.2B-$4.3B; 26/04/2018 – Leggett & Platt 1Q EPS 57c; 15/05/2018 – Leggett & Platt Raises Dividend to 38c; 09/03/2018 Leggett & Platt Volume Rises More Than Triple 20 Day Average; 26/04/2018 – Leggett & Platt Had Seen 2018 EPS $2.65 to $2.85; 26/04/2018 – LEGGETT & PLATT INC – RAW MATERIAL-RELATED PRICE INCREASES AND CURRENCY IMPACT SHOULD ALSO CONTRIBUTE TO SALES GROWTH IN 2018; 14/05/2018 – Epoch Investment Partners Buys 2.3% Position in Leggett & Platt; 19/04/2018 – Leggett & Platt Closes Below 50-Day Moving Average: Technicals; 26/04/2018 – LEGGETT & PLATT SEES FY EPS $2.60 TO $2.60, EST. $2.76

Veritas Asset Management Llp decreased Thermo Fisher Scientific Inc (TMO) stake by 6.95% reported in 2018Q4 SEC filing. Veritas Asset Management Llp sold 218,045 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 4.87%. The Veritas Asset Management Llp holds 2.92M shares with $652.91M value, down from 3.14M last quarter. Thermo Fisher Scientific Inc now has $104.93B valuation. The stock increased 0.60% or $1.56 during the last trading session, reaching $262.99. About 998,073 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 26.43% since March 15, 2018 and is uptrending. It has outperformed by 22.06% the S&P500. Some Historical TMO News: 29/05/2018 – VIKRAM THERMO (INDIA) LTD VKMT.BO SAYS CO RECOMMENDED DIVIDEND AT 5 PCT; 25/04/2018 – THERMO FISHER 1Q REV. $5.85B, EST. $5.63B; 09/03/2018 – Skyland Analytics Appoints James C. Mullen, Former Biogen and Patheon CEO, to Advisory Board; 07/05/2018 – New Thermo Scientific Prisma SEM Combines Performance and Versatility; 25/04/2018 – Globalstar Merger Will Organize the Pro Forma Co Into Four Principal Operating Subsidiaries Under the Name Thermo Companies as the Public Co; 25/04/2018 – Thermo Fisher Scientific 1Q Profit Increases; Lifts Guidance; 29/05/2018 – Thermo King “Moves Food” to Increase Food Security; 25/04/2018 – Thermo Fisher 1Q Organic Revenue Growth 7%; 09/05/2018 – Thermo Fisher Presenting at Bank of America Conference May 16; 28/03/2018 – BIOCEPT, THERMO PACT INCL VALIDATATION OF THERMO’S ONCOMINE

Investors sentiment increased to 0.89 in 2018 Q4. Its up 0.04, from 0.85 in 2018Q3. It increased, as 38 investors sold TMO shares while 451 reduced holdings. 123 funds opened positions while 313 raised stakes. 354.55 million shares or 6.33% more from 333.46 million shares in 2018Q3 were reported. Jnba Advisors holds 0% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 87 shares. Price T Rowe Associate Md has invested 0.6% in Thermo Fisher Scientific Inc. (NYSE:TMO). Icon Advisers reported 60,346 shares. Cypress Mngmt Ltd Llc invested in 0.17% or 3,675 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0.21% in Thermo Fisher Scientific Inc. (NYSE:TMO). Pillar Pacific Capital Management Lc invested 1.73% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). The Maryland-based Brown Advisory Securities Ltd Liability Co has invested 0.1% in Thermo Fisher Scientific Inc. (NYSE:TMO). Compton Cap Mngmt Inc Ri holds 1.86% or 17,390 shares. Parallax Volatility Advisers LP reported 0.01% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Eulav Asset Mngmt invested in 0.44% or 39,300 shares. E&G Limited Partnership reported 998 shares. Consolidated Investment Grp Inc Ltd has invested 3.18% in Thermo Fisher Scientific Inc. (NYSE:TMO). Banced Corp stated it has 2,211 shares or 1.07% of all its holdings. Freestone Cap Ltd Liability Company stated it has 0.15% in Thermo Fisher Scientific Inc. (NYSE:TMO). Security National owns 19,763 shares or 1.64% of their US portfolio.

Veritas Asset Management Llp increased Cvs Health Corp (NYSE:CVS) stake by 214,957 shares to 11.92M valued at $781.28M in 2018Q4. It also upped Dentsply Sirona Inc stake by 1.54 million shares and now owns 13.47M shares. Baxter International Inc (NYSE:BAX) was raised too.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 24. They expect $2.73 earnings per share, up 9.20% or $0.23 from last year’s $2.5 per share. TMO’s profit will be $1.09B for 24.08 P/E if the $2.73 EPS becomes a reality. After $3.25 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -16.00% negative EPS growth.

Among 7 analysts covering Thermo Fisher Scientific (NYSE:TMO), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Thermo Fisher Scientific had 11 analyst reports since September 17, 2018 according to SRatingsIntel. The stock has “Buy” rating by Barclays Capital on Tuesday, March 5. As per Thursday, October 25, the company rating was maintained by Morgan Stanley. Barclays Capital maintained the shares of TMO in report on Thursday, January 3 with “Overweight” rating. Barclays Capital maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Monday, September 24. Barclays Capital has “Overweight” rating and $275 target. Cleveland downgraded the stock to “Neutral” rating in Thursday, October 18 report. Morgan Stanley maintained it with “Overweight” rating and $254 target in Wednesday, October 10 report. The firm earned “Outperform” rating on Thursday, October 25 by Robert W. Baird. The company was downgraded on Monday, September 17 by Goldman Sachs. Citigroup maintained the stock with “Buy” rating in Wednesday, October 10 report.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Thermo Fisher files for mixed shelf offering – Seeking Alpha” on February 28, 2019, also Seekingalpha.com with their article: “Expanded use for Thermo Fisher CDx test OK’d in Japan – Seeking Alpha” published on February 26, 2019, Seekingalpha.com published: “Thermo Fisher Scientific declares $0.17 dividend – Seeking Alpha” on November 08, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Seekingalpha.com and their article: “Thermo Fisher in-licenses CRISPR technologies – Seeking Alpha” published on September 18, 2018 as well as Benzinga.com‘s news article titled: “Thermo Fisher Scientific Inc (NYSE:TMO) – Q3 Earnings Preview: Thermo Fisher Scientific – Benzinga” with publication date: October 23, 2018.

Since October 1, 2018, it had 0 insider purchases, and 5 sales for $39.04 million activity. Herrema Gregory J. sold $4.26 million worth of stock or 17,235 shares. $31.07 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by CASPER MARC N on Monday, October 1. 9,500 shares were sold by Williamson Stephen, worth $2.29M. $1.14M worth of stock was sold by Jacks Tyler on Monday, November 19.

More notable recent Leggett & Platt, Incorporated (NYSE:LEG) news were published by: Investorplace.com which released: “3 Big Stock Charts for Friday: Medtronic, LKQ and Lamb Weston – Investorplace.com” on March 15, 2019, also Nasdaq.com with their article: “Walmart and Domino’s: The New Tech Stocks? – Nasdaq” published on March 15, 2019, Seekingalpha.com published: “Long Energy Transfer Before Earnings – Seeking Alpha” on February 14, 2019. More interesting news about Leggett & Platt, Incorporated (NYSE:LEG) were released by: Benzinga.com and their article: “Warren Buffett, Other Kraft Heinz (NYSE:KHC) Institutional Investors Left With Mustard On Their Shirts – Benzinga” published on February 22, 2019 as well as Seekingalpha.com‘s news article titled: “Stocks To Watch: Big Pharma, Green Trucks And Jobs Report – Seeking Alpha” with publication date: March 02, 2019.

Investors sentiment decreased to 0.91 in 2018 Q4. Its down 0.15, from 1.06 in 2018Q3. It worsened, as 42 investors sold LEG shares while 129 reduced holdings. 36 funds opened positions while 119 raised stakes. 100.68 million shares or 4.82% more from 96.05 million shares in 2018Q3 were reported. Gp has invested 0.01% in Leggett & Platt, Incorporated (NYSE:LEG). Synovus Fincl has invested 0.02% in Leggett & Platt, Incorporated (NYSE:LEG). Barclays Public Ltd Company owns 163,736 shares. Villere St Denis J And Ltd Liability Company owns 1.50 million shares for 3.8% of their portfolio. Ftb holds 182 shares. Peninsula Asset Mgmt stated it has 0.76% of its portfolio in Leggett & Platt, Incorporated (NYSE:LEG). 300 were accumulated by Motco. Manchester Management Ltd Liability Corporation has invested 0.01% in Leggett & Platt, Incorporated (NYSE:LEG). Utah Retirement Systems holds 0.02% or 24,376 shares. The Illinois-based Gp One Trading LP has invested 0% in Leggett & Platt, Incorporated (NYSE:LEG). Pub Employees Retirement Sys Of Ohio stated it has 0.01% of its portfolio in Leggett & Platt, Incorporated (NYSE:LEG). The Switzerland-based Swiss Bankshares has invested 0.02% in Leggett & Platt, Incorporated (NYSE:LEG). Vanguard Group holds 14.26M shares. Lazard Asset Management Ltd Liability stated it has 0.04% of its portfolio in Leggett & Platt, Incorporated (NYSE:LEG). Panagora Asset Mngmt reported 89,055 shares.

Analysts await Leggett & Platt, Incorporated (NYSE:LEG) to report earnings on April, 25. They expect $0.56 earnings per share, down 1.75% or $0.01 from last year’s $0.57 per share. LEG’s profit will be $73.40 million for 19.25 P/E if the $0.56 EPS becomes a reality. After $0.62 actual earnings per share reported by Leggett & Platt, Incorporated for the previous quarter, Wall Street now forecasts -9.68% negative EPS growth.

Since February 14, 2019, it had 0 insider buys, and 1 insider sale for $444,544 activity. $444,544 worth of Leggett & Platt, Incorporated (NYSE:LEG) was sold by MCCLANATHAN JOSEPH W on Thursday, February 14.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart